DT2216
CAS : 2365172-42-3
Ref. 3D-QUD17242
1mg | 455,00 € | ||
2mg | 711,00 € | ||
5mg | 1.276,00 € | ||
10mg | 2.041,00 € | ||
500µg | 341,00 € |
Informations sur le produit
DT2216 is a molecule that inhibits the ubiquitin-proteasome system (UPS) and regulates protein levels. DT2216 has been shown to have potent antitumor activity in animal models of cancer, including breast, colon, and lung cancers. This drug has also been shown to inhibit the growth of leukemia cells and t-cell lymphomas in cell culture. The mechanism of action appears to be related to the ability of DT2216 to impair the function of cytosolic protein kinase C (PKC), which is involved in tumor cell proliferation and survival. DT2216 has been found to synergize with other drugs used for cancer treatment such as vincristine, carboplatin, paclitaxel, cisplatin, tamoxifen, or docetaxel.
Propriétés chimiques
Question d’ordre technique sur : 3D-QUD17242 DT2216
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages